米国のリプロセス医療機器市場規模、シェア、動向分析レポート：製品タイプ別、用途別、セグメント別予測、2024年-2030年

米国のリプロセス医療機器市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、米国のリプロセス医療機器市場規模は2030年までに30億9,000万米ドルに達し、予測期間中にCAGR 16.3％で拡大すると予測されています。

シングルユースデバイスの多くは高価であり、再処理することで病院やヘルスケア施設はかなりの金額を節約することができます。Innovative HealthやStrykerのような評判の高いリプロセスブランドは、厳格な品質管理基準と規制要件を遵守しています。厳格なガイドラインと基準は、再加工された器具が新品と同じ品質と安全性の要件を満たすことを保証するために設けられています。これにより、患者は、高価になる可能性のある新しい器具を使用する必要なく、高品質の治療を受けることができます。

毎回、新しい医療機器よりもこうした再加工された医療機器の使用が増えることは、資源の節約とコスト削減につながります。例えば、医療機器再処理業者協会（AMDR）が発表した情報によると、再処理されたシングルユース医療機器を最大限に使用することで、米国の病院は年間約22億8,000万米ドルを節約することができます。

患者の安全を守り、機器の有効性を維持するために、再加工された医療機器は厳しい品質管理と滅菌手順を経る必要があります。FDAは、再加工を受けたものを含む医療機器の有効性、安全性、品質の保証を監督しています。再加工された医療機器は、さらに使用するために消毒、洗浄、包装されているため、「単回使用機器」に分類されます。連邦食品・医薬品・化粧品法（FDA）の医療機器法改正に基づき、FDAはこれらの機器の規制を監督しています。再加工された医療機器の製造者は、その医療機器を市場に出す前に、FDAの許可または承認を受け、一定の品質システム要件を遵守しなければなりません。

米国のリプロセス医療機器市場レポート・ハイライト

• 2023年の製品分野別シェアは、心臓血管分野が56.5%で優位を占めており、予測期間中に最も速いCAGRで成長すると予測されています。この高い有病率は、心血管治療や診断に使用される医療機器の大きな需要につながり、ひいてはリプロセス医療機器の需要を生み出しています。
• 2023年には、サードパーティリプロセシングセグメントが最大の市場シェアを占めました。サードパーティ・リプロセシング企業は、医療機器のリプロセシングに費用対効果の高いソリューションを提供しています。
• 2023年、病院が最終用途セグメントを支配しました。病院やヘルスケア施設は、新しいシングルユースのデバイスを購入するのに比べて大幅なコスト削減ができるため、リプロセス医療デバイスを使用しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 米国のリプロセス医療機器市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場牽引要因分析
  • 市場抑制要因分析
• 米国のリプロセス医療機器市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析

第4章 米国のリプロセス医療機器市場：製品タイプの推定・動向分析

• 市場シェア、2023年と2030年
• セグメントダッシュボード
• 製品タイプ別市場の見通し
• 市場規模と予測および動向分析、2018年～2030年

第5章 米国のリプロセス医療機器市場：タイプの推定・動向分析

• 市場シェア、2023年と2030年
• セグメントダッシュボード
• タイプ別市場の見通し
• 市場規模と予測および動向分析、2018年～2030年

第6章 米国のリプロセス医療機器市場：最終用途の推定・動向分析

• 市場シェア、2023年と2030年
• セグメントダッシュボード
• 最終用途別市場の見通し
• 市場規模と予測および動向分析、2018年～2030年

第7章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業/競合の分類
• ベンダー情勢
• 企業プロファイル
  • Stryker
  • Innovative Health
  • NEScientific, Inc.
  • Medline Industries, Inc.
  • Arjo
  • Vanguard AG
  • Cardinal Health
  • SureTek Medical
  • Soma Tech Medical
  • Johnson &Johnson Services, Inc.

List of Tables

• Table 1 List of abbreviations
• Table 2 U.S. reprocessed medical devices market, by product, 2018 - 2030 (USD Million)
• Table 3 U.S. reprocessed medical devices market, by type, 2018 - 2030 (USD Million)
• Table 4 U.S. reprocessed medical devices market, by end-use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Primary interviews
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 U.S. reprocessed medical devices market: Market outlook
• Fig. 10 Competitive insights
• Fig. 11 Parent market outlook
• Fig. 12 Related/ancillary market outlook
• Fig. 13 Penetration and growth prospect mapping
• Fig. 14 U.S. reprocessed medical devices market driver impact
• Fig. 15 U.S. reprocessed medical devices market restraint impact
• Fig. 16 U.S. reprocessed medical devices market: Product movement analysis
• Fig. 17 U.S. reprocessed medical devices market: Product outlook and key takeaways
• Fig. 18 Cardiovascular market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 19 Blood pressure cuffs market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 20 Positioning devices market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 21 Cardiac stabilization devices market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 22 Diagnostic electrophysiology catheters market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 23 Deep vein thrombosis compression sleeves market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 24 Electrophysiology cables market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 25 Laparoscopic market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 26 Harmonic scalpels market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 27 Endoscopic trocars market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 28 Gastroenterology market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 29 Biopsy forceps market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 30 Others market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 31 General surgery market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 32 Pressure bags market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 33 Balloon inflation devices market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 34 Orthopedic market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 35 U.S. reprocessed medical devices market: Type movement analysis
• Fig. 36 U.S. reprocessed medical devices market: Type outlook and key takeaways
• Fig. 37 3rd party reprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 38 In-house reprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 39 U.S. reprocessed medical devices market: End-use movement analysis
• Fig. 40 U.S. reprocessed medical devices market: End-use outlook and key takeaways
• Fig. 41 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 42 Home healthcare market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 43 Others market estimates and forecasts, 2018 - 2030 (USD Million)

U.S. Reprocessed Medical Devices Market Growth & Trends:

The U.S. reprocessed medical devices market size is anticipated to reach USD 3.09 billion by 2030 and is anticipated to expand at a CAGR of 16.3% during the forecast period, according to a new report by Grand View Research, Inc. Many single-use devices are expensive and reprocessing them can help hospitals and healthcare facilities save a considerable amount of money. Reputable reprocess brands, such as Innovative Health and Stryker, adhere to strict quality control standards and regulatory requirements. Strict guidelines and standards are in place to ensure that reprocessed devices meet the same quality and safety requirements as new ones. This allows patients to receive high-quality care without the need to use new, potentially more expensive devices.

The increasing usage of these reprocessed medical devices over the newer ones every time leads to saving resources and cutting costs. For instance, as per the information published by the Association of Medical Device Reprocessors (AMDR), maximizing the use of reprocessed single-use medical devices can help hospitals in the U.S. to save approximately USD 2.28 billion annually.

To protect patient safety and preserve device efficacy, reprocessed medical devices need to go through stringent quality control and sterilizing procedures. The FDA oversees guaranteeing the efficacy, safety, and quality of medical devices, including ones that have undergone reprocessing. Reprocessed medical devices are classified as "single-use devices" since they have been sanitized, cleaned, and packed for further use. Under the Federal Food, Drug, and Cosmetic Act's Medical Device Amendments, the FDA oversees regulating these devices. Before putting their devices on the market, manufacturers of reprocessed devices have to get FDA clearance or approval and adhere to certain quality system requirements.

U.S. Reprocessed Medical Devices Market Report Highlights:

• The cardiovascular segment dominated the product segment with 56.5% share in 2023 and is expected to grow at the fastest CAGR over the forecast period. This high prevalence leads to a significant demand for medical devices used in cardiovascular treatments and diagnostics, which, in turn, creates demand for reprocessed medical devices
• The 3rd party reprocessing segment held the largest market share in 2023. Third-party reprocessing companies offer cost-effective solutions for reprocessing medical devices
• Hospitals dominated the end-use segment in 2023. Hospitals and healthcare facilities use reprocessed medical devices as they offer significant cost savings compared to purchasing new, single-use devices

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product type
  • 1.2.2. Type
  • 1.2.3. End-use
  • 1.2.4. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Volume price analysis (Model 2)
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product type outlook
  • 2.2.2. Type outlook
  • 2.2.3. End-use outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Reprocessed Medical Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising incidence of diseases
    • 3.2.1.2. Technological advancements in healthcare
    • 3.2.1.3. Increasing emphasize on costs cutting
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Stringent regulations & approvals
• 3.3. U.S. Reprocessed Medical Devices Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. U.S. Reprocessed Medical Devices Market: Product Type Estimates & Trend Analysis

• 4.1. Product Market Share, 2023 & 2030
• 4.2. Segment Dashboard
• 4.3. U.S. Reprocessed Medical Devices Market by Product Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
  • 4.4.1. Cardiovascular
    • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.2. Blood pressure cuffs
    • 4.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.3. Positioning devices
    • 4.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.4. Cardiac stabilization devices
    • 4.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.5. Diagnostic electrophysiology catheters
    • 4.4.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.6. Deep vein thrombosis compression sleeves
    • 4.4.1.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.7. Electrophysiology cables
    • 4.4.1.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.2. Laparoscopic
    • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2.2. Harmonic scalpels
    • 4.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2.3. Endoscopic trocars
    • 4.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.3. Gastroenterology
    • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3.2. Biopsy forceps
    • 4.4.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3.3. Others
    • 4.4.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.4. General surgery
    • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4.2. Pressure bags
    • 4.4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4.3. Balloon inflation devices
    • 4.4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.5. Orthopedic
    • 4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. U.S. Reprocessed Medical Devices Market: Type Estimates & Trend Analysis

• 5.1. Type Market Share, 2023 & 2030
• 5.2. Segment Dashboard
• 5.3. U.S. Reprocessed Medical Devices Market by Type Outlook
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
  • 5.4.1. 3rd party reprocessing
    • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.2. In-house reprocessing
    • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. U.S. Reprocessed Medical Devices Market: End-use Estimates & Trend Analysis

• 6.1. End-use Market Share, 2023 & 2030
• 6.2. Segment Dashboard
• 6.3. U.S. Reprocessed Medical Devices Market by End-use Outlook
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
  • 6.4.1. Hospitals
    • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
  • 6.4.2. Home healthcare
    • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.3. Others
    • 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
• 7.3. Vendor Landscape
  • 7.3.1. List of key distributors and channel partners
  • 7.3.2. Key customers
  • 7.3.3. Key company heat map analysis, 2023
• 7.4. Company Profiles
  • 7.4.1. Stryker
    • 7.4.1.1. Company overview
    • 7.4.1.2. Financial performance
    • 7.4.1.3. Product benchmarking
    • 7.4.1.4. Strategic initiatives
  • 7.4.2. Innovative Health
    • 7.4.2.1. Company overview
    • 7.4.2.2. Financial performance
    • 7.4.2.3. Product benchmarking
    • 7.4.2.4. Strategic initiatives
  • 7.4.3. NEScientific, Inc.
    • 7.4.3.1. Company overview
    • 7.4.3.2. Financial performance
    • 7.4.3.3. Product benchmarking
    • 7.4.3.4. Strategic initiatives
  • 7.4.4. Medline Industries, Inc.
    • 7.4.4.1. Company overview
    • 7.4.4.2. Financial performance
    • 7.4.4.3. Product benchmarking
    • 7.4.4.4. Strategic initiatives
  • 7.4.5. Arjo
    • 7.4.5.1. Company overview
    • 7.4.5.2. Financial performance
    • 7.4.5.3. Product benchmarking
    • 7.4.5.4. Strategic initiatives
  • 7.4.6. Vanguard AG
    • 7.4.6.1. Company overview
    • 7.4.6.2. Financial performance
    • 7.4.6.3. Product benchmarking
    • 7.4.6.4. Strategic initiatives
  • 7.4.7. Cardinal Health
    • 7.4.7.1. Company overview
    • 7.4.7.2. Financial performance
    • 7.4.7.3. Product benchmarking
    • 7.4.7.4. Strategic initiatives
  • 7.4.8. SureTek Medical
    • 7.4.8.1. Company overview
    • 7.4.8.2. Financial performance
    • 7.4.8.3. Product benchmarking
    • 7.4.8.4. Strategic initiatives
  • 7.4.9. Soma Tech Medical
    • 7.4.9.1. Company overview
    • 7.4.9.2. Financial performance
    • 7.4.9.3. Product benchmarking
    • 7.4.9.4. Strategic initiatives
  • 7.4.10. Johnson & Johnson Services, Inc.
    • 7.4.10.1. Company overview
    • 7.4.10.2. Financial performance
    • 7.4.10.3. Product benchmarking
    • 7.4.10.4. Strategic initiatives